We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$42.7B
AUM Growth
+$713M
Cap. Flow
-$1.02B
Cap. Flow %
-2.39%
Top 10 Hldgs %
6.08%
Holding
1,876
New
75
Increased
1,071
Reduced
591
Closed
69

Sector Composition

Rank Sector Weight
1 Financials 18.6%
2 Industrials 14.61%
3 Technology 14.32%
4 Consumer Discretionary 10.63%
5 Healthcare 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPP
1701
Hudson Pacific Properties
HPP
$747M
$44K ﹤0.01%
186
+47
+34% +$11.3K
ACIA
1702
DELISTED
Acacia Communications Inc
ACIA
$44K ﹤0.01%
1,060
+157
+17% +$7.55K
MZTI
1703
The Marzetti Company
MZTI
$2.93B
$39K ﹤0.01%
+315
New +$39.5K
CSTE icon
1704
Caesarstone
CSTE
$72.3M
$38K ﹤0.01%
1,087
+19
+2% +$712
DEI icon
1705
Douglas Emmett
DEI
$1.98B
$38K ﹤0.01%
1,005
-40
-4% -$1.54K
PEB icon
1706
Pebblebrook Hotel Trust
PEB
$2.15B
$36K ﹤0.01%
1,125
+110
+11% +$3.43K
IQV icon
1707
IQVIA
IQV
$38.7B
$35K ﹤0.01%
395
ADXS
1708
DELISTED
Advaxis Inc
ADXS
$35K ﹤0.01%
354
+215
+155% +$25.2K
CORI
1709
DELISTED
Corium International, Inc.
CORI
$35K ﹤0.01%
4,686
+80
+2% +$476
FOMX
1710
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$34K ﹤0.01%
7,252
+2,941
+68% +$13.1K
IMMR icon
1711
Immersion
IMMR
$251M
$33K ﹤0.01%
3,678
+63
+2% +$543
RIGL icon
1712
Rigel Pharmaceuticals
RIGL
$681M
$32K ﹤0.01%
1,165
+466
+67% +$12.8K
CPT icon
1713
Camden Property Trust
CPT
$11B
$31K ﹤0.01%
360
OMER icon
1714
Omeros
OMER
$857M
$31K ﹤0.01%
1,570
+48
+3% +$838
TGTX icon
1715
TG Therapeutics
TGTX
$7.96B
$31K ﹤0.01%
3,056
+1,078
+54% +$12.1K
IONS icon
1716
Ionis Pharmaceuticals
IONS
$8.6B
$30K ﹤0.01%
591
+10
+2% +$466
NBIX icon
1717
Neurocrine Biosciences
NBIX
$16.8B
$30K ﹤0.01%
660
+11
+2% +$534
TLGT
1718
DELISTED
Teligent, Inc
TLGT
$30K ﹤0.01%
331
+5
+2% +$426
NWS icon
1719
News Corp Class B
NWS
$16.9B
$29K ﹤0.01%
2,064
-115
-5% -$1.55K
LHO
1720
DELISTED
LaSalle Hotel Properties
LHO
$29K ﹤0.01%
970
-30
-3% -$881
RARE icon
1721
Ultragenyx Pharmaceutical
RARE
$2.45B
$28K ﹤0.01%
443
+43
+11% +$2.59K
LXRX icon
1722
Lexicon Pharmaceuticals
LXRX
$1.03B
$26K ﹤0.01%
1,557
+27
+2% +$418
ACFC
1723
DELISTED
Atlantic Coast Financial Corporation
ACFC
$26K ﹤0.01%
3,362
WOOF
1724
DELISTED
VCA Inc.
WOOF
$26K ﹤0.01%
284
OHI icon
1725
Omega Healthcare
OHI
$15.1B
$25K ﹤0.01%
745

Similar funds

Victory Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Victory Capital Management held 1,876 positions worth $42.7B, up 1.7% from $42B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Victory Capital Management's Q2 2017 filing shows 75 new, 1,071 increased, 591 reduced and 69 closed positions. Its largest new stake was DXC Technology: 2,390,939 shares worth $159M. The largest sale was Pinnacle Foods, Inc., an estimated $120M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q2 2017 buy was DXC Technology: 2,390,939 shares worth $159M.
  • Victory Capital Management added most to Fidelity National Financial in Q2 2017, an estimated $169M increase.
  • Victory Capital Management's biggest Q2 2017 reduction was Pinnacle Foods, Inc., cutting an estimated $120M.
  • Victory Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $112M.
  • Victory Capital Management's ten largest holdings make up 6.1% of its $42.7B portfolio in Q2 2017.
  • Victory Capital Management opened 75 new positions and closed 69 in Q2 2017.
  • Victory Capital Management's portfolio value rose 1.7% quarter-over-quarter to $42.7B.

Based on Victory Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.